Global Diagnostic Enzymes Market Size & Outlook

The diagnostic enzymes industry worldwide is expected to reach a projected revenue of US$ 6,264.2 million by 2030. A compound annual growth rate of 4.5% is expected of the worldwide diagnostic enzymes industry from 2024 to 2030.

Revenue, 2023 (US$M)
$4,597.9
Forecast, 2030 (US$M)
$6,264.2
CAGR, 2024 - 2030
4.5%
Report Coverage
Worldwide

Global diagnostic enzymes market highlights

  • The global diagnostic enzymes market generated a revenue of USD 4,597.9 million in 2023 and is expected to reach USD 6,264.2 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 4.5% by 2030.
  • In terms of segment, other type accounted for a revenue of USD 757.6 million in 2023.
  • Lactate dehydrogenase is the most lucrative type segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.
  • Country-wise, Norway is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 4,597.9 million
Market revenue in 2030USD 6,264.2 million
Growth rate4.5% (CAGR from 2023 to 2030)
Largest segmentOther type
Fastest growing segmentLactate dehydrogenase
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTaq polymerase, MMLV RT, HIV RT, Hot start Taq pol, UNG, RNase inhibitor, Bst polymerase (LAMP enzyme), PCR Master Mix, Lyophilised Polymerase, T7 RNA polymerase, Cas9 enzyme, Acid phosphatase, Alanine aminotransferase, Alkaline phosphatase, Amylase, Angiotensin converting enzyme, Aspartate aminotransferase, Cholinesterase, Creatinine kinase, Gamma glutamyl transferase, Lactate dehydrogenase, Renin, Glucose oxidase/glucose dehydrogenase, Urease, Lactate oxidase, Horseradish peroxidase, Glutamate oxidase, Other Type

Other key industry trends

  • In terms of revenue, the North America accounted for 44.0% of the global diagnostic enzymes market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Norway is the fastest growing regional market and is projected to reach USD 30.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Diagnostic Enzymes Market Scope

Diagnostic enzymes market segmentation & scope
Taq polymerase
MMLV RT
HIV RT
Hot start Taq pol
UNG
RNase inhibitor
Bst polymerase (LAMP enzyme)
PCR Master Mix
Lyophilised Polymerase
T7 RNA polymerase
Cas9 enzyme
Acid phosphatase
Alanine aminotransferase
Alkaline phosphatase
Amylase
Angiotensin converting enzyme
Aspartate aminotransferase
Cholinesterase
Creatinine kinase
Gamma glutamyl transferase
Lactate dehydrogenase
Renin
Glucose oxidase/glucose dehydrogenase
Urease
Lactate oxidase
Horseradish peroxidase
Glutamate oxidase
Other Type
Diabetes
Oncology
Cardiology
Infectious Diseases
Nephrology
Autoimmune Diseases
Others
Product
Molecular Enzymes
Clinical Enzymes

Diagnostic Enzymes Market Companies

Name Profile # Employees HQ Website

Global diagnostic enzymes market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diagnostic enzymes market will help companies and investors design strategic landscapes.


other type was the largest segment with a revenue share of 16.48% in 2023. Horizon Databook has segmented the Global diagnostic enzymes market based on taq polymerase, mmlv rt, hiv rt, hot start taq pol, ung, rnase inhibitor, bst polymerase (lamp enzyme), pcr master mix, lyophilised polymerase, t7 rna polymerase, cas9 enzyme, acid phosphatase, alanine aminotransferase, alkaline phosphatase, amylase, angiotensin converting enzyme, aspartate aminotransferase, cholinesterase, creatinine kinase, gamma glutamyl transferase, lactate dehydrogenase, renin, glucose oxidase/glucose dehydrogenase, urease, lactate oxidase, horseradish peroxidase, glutamate oxidase, other type covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Diagnostic Enzymes Type Outlook (Revenue, USD Million, 2018-2030)
    • Taq polymerase
    • MMLV RT
    • HIV RT
    • Hot start Taq pol
    • UNG
    • RNase inhibitor
    • Bst polymerase (LAMP enzyme)
    • PCR Master Mix
    • Lyophilised Polymerase
    • T7 RNA polymerase
    • Cas9 enzyme
    • Acid phosphatase
    • Alanine aminotransferase
    • Alkaline phosphatase
    • Amylase
    • Angiotensin converting enzyme
    • Aspartate aminotransferase
    • Cholinesterase
    • Creatinine kinase
    • Gamma glutamyl transferase
    • Lactate dehydrogenase
    • Renin
    • Glucose oxidase/glucose dehydrogenase
    • Urease
    • Lactate oxidase
    • Horseradish peroxidase
    • Glutamate oxidase
    • Other Type
  • Global Diagnostic Enzymes Application Outlook (Revenue, USD Million, 2018-2030)
    • Diabetes
    • Oncology
    • Cardiology
    • Infectious Diseases
    • Nephrology
    • Autoimmune Diseases
    • Others
  • Global Diagnostic Enzymes Product Outlook (Revenue, USD Million, 2018-2030)
    • Molecular Enzymes
    • Clinical Enzymes

Reasons to subscribe to Global diagnostic enzymes market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global diagnostic enzymes market databook

  • Our clientele includes a mix of diagnostic enzymes market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global diagnostic enzymes market , including forecasts for subscribers. This global databook contains high-level insights into Global diagnostic enzymes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global diagnostic enzymes market statistics, by regions, 2018-2030 (US$M)

Top 10 countries: Diagnostic enzymes market size, 2023 (USD Million)

Top 10 countries: Diagnostic enzymes market size, 2023 (USD Million)

Global diagnostic enzymes market, by region, 2023 (US$M)

Global diagnostic enzymes market statistics, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more